Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
James Hardie Industries
JHX
|
+$17.5M |
| 2 |
Columbia Banking Systems
COLB
|
+$16.2M |
| 3 |
Dolby
DLB
|
+$11.8M |
| 4 |
Hilton Grand Vacations
HGV
|
+$11.6M |
| 5 |
Knight Transportation
KNX
|
+$10.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AZEK
The AZEK Co
AZEK
|
+$38.7M |
| 2 |
Dycom Industries
DY
|
+$23.3M |
| 3 |
Supernus Pharmaceuticals
SUPN
|
+$20.3M |
| 4 |
TKO Group
TKO
|
+$17.9M |
| 5 |
Itron
ITRI
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.9% |
| 2 | Technology | 20.69% |
| 3 | Financials | 15.7% |
| 4 | Healthcare | 13.43% |
| 5 | Consumer Discretionary | 8.22% |
Similar funds
Aristotle Capital Boston's Q3 2025 Portfolio in Review
As of Q3 2025, Aristotle Capital Boston held 135 positions worth $1.94B, down 1.2% from $1.96B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aristotle Capital Boston withdrew a net $64.7M in Q3 2025, closing 8 positions and reducing 90 holdings. Its most notable exit was The AZEK Co, an estimated $38.7M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 25% a quarter earlier, followed by Technology and Financials.
Against the trend, Aristotle Capital Boston opened a new position in James Hardie Industries worth $14M.
- Aristotle Capital Boston's largest Q3 2025 buy was James Hardie Industries: 729,798 shares worth $14M.
- Aristotle Capital Boston added most to Dolby in Q3 2025, an estimated $11.8M increase.
- Aristotle Capital Boston's biggest Q3 2025 reduction was Dycom Industries, cutting an estimated $23.3M.
- Aristotle Capital Boston fully exited The AZEK Co in Q3 2025, selling an estimated $38.7M.
- Aristotle Capital Boston's ten largest holdings make up 22% of its $1.94B portfolio in Q3 2025.
- Aristotle Capital Boston opened 8 new positions and closed 8 in Q3 2025.
- Aristotle Capital Boston's portfolio value fell 1.2% quarter-over-quarter to $1.94B.
Based on Aristotle Capital Boston's 13F filing for Q3 2025, filed 14 Nov 2025.